1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
Follow CT-P13: new trials by email Literature Review of CT-P13 trials Research Report on CT-P13
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial Infliximab-dyyb Biosimilar (Remsima) - Moderate to Severe Chronic Plaque Psoriasis | Phase 1 / Phase 2 | Unknown | Services Institute of Medical Sciences, Pakistan | 104 | 2023-11-06 | 2024-09-19 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 800 | 2021-02-21 | 2026-07-15 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
| A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis CT-P13 - Crohn's Disease, Ulcerative Colitis (Part 2 Only) | Phase 1 | Completed | Celltrion | 181 | 2016-09-29 | 2020-06-09 |
Carcinoma, Non-Small-Cell Lung (2) · Colitis (2) · Urogenital Neoplasms (2) · Colitis, Ulcerative (1) · Crohn Disease (1) · Lung Neoplasms (1) · Melanoma (1)
M.D. Anderson Cancer Center (2) · Celltrion (1) · Services Institute of Medical Sciences, Pakistan (1)
United States (2) · Pakistan (1) · South Korea (1)
Yinghong Wang (2) · Dr Hira Tariq, MBBS, FCPS Derma (1) · MoonSun Choi (1)
PMID 33676969, PMID 37004656, PMID 38365502
2016 (1)